Navigation Links
NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING
Date:6/3/2008

MISSISSAUGA, ON, June 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that clinical data from three clinical trials of its anti-cancer drug nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor, were presented at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 30 to June 3, 2008.

"The breadth of data presented at ASCO highlights the promise nimotuzumab holds for a diverse group of oncology patients," said David Allan, Chairman and CEO of YM BioSciences. "In each of these trials, results further demonstrated the unique potential for nimotuzumab to be an effective EGFR-targeting antibody without deleterious side-effects observed with the other drugs in its class."

"Phase III trial of nimotuzumab for the treatment of newly diagnosed

diffuse intrinsic pontine gliomas in children and adolescents" (Abstract

number 2058):

This poster reported data from a multi-centre Phase III study evaluating the feasibility and efficacy of nimotuzumab as the primary treatment for these patients. Between March 2006 and August 2007, 42 patients aged 3 to 16 years (median 7 years) were enrolled in this study, with 41 patients evaluable for response. The primary endpoint for the trial is median progression free survival at six months after diagnosis. Secondary endpoints include overall survival, response rate, toxicity and quality of life.

The poster presentation described preliminary results including that the median progression free survival was 5.9 months, that the median
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES REPORTS NIMOTUZUMAB NSCLC CLINICAL DATA AT ASCO ANNUAL MEETING
2. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB COLORECTAL CANCER TRIAL FIRST COHORT IS CLOSED TO ACCRUAL
3. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
4. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
5. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
8. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
9. Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
10. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
11. Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  Lisa Kulik saw fireworks for the ... holiday, thanks to a groundbreaking retinal implant co-invented by ... clinician-researcher at the University of Southern California (USC) Eye ... Peoria, Ariz. resident who has retinitis pigmentosa, ... sight. On June 2, she became the first person ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 “We are ... technology vendors,” said Ven Thangaraj, CEO of Radiant Sage. ... that are taking the imaging corelab market to a ... corelabs and research organizations to efficiently and effectively manage ... the data to be analyzed and read by trained ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... The Graphene Opportunity - A Rational View ... Graphene The New Nanotech? A similar amount ... of applications ranging from microelectronics to water treatment, ... announced the availability of the Graphene Opportunity Report, ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... for Pulp & Paper Industry Report 2014" report ... for Pulp & Paper Industry Report 2014 is a ... the global enzyme for pulp & paper industry. ... industry including definitions, classifications, applications and industry chain structure. ...
Breaking Biology Technology:USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 2USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 3USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 4USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States 5Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Enzyme for Pulp & Paper Industry Report 2014 2
... , ... , New Brunswick Scientific now ... mass from anchorage-dependent or suspension cultures.,More productive than traditional roller bottles,spinners or ... operate, and disposable. Typical,yields of 4.9 x 10 9 cells per ...
... , ... An advanced new benchtop fermentor and cell ... you to optimize process control by,integrating data from up to ... analyzers, supplementary,pumps, cell mass sensors, and so on, can be ...
... , ... This Application Report is part of a ... BioFlo 110 can be used to efficiently grow mammalian cells, plant cells,insect cells, yeast, ... For this report, a standard 7.5L BioFlo 110 Advanced Fermentation Kit, NBS Catalog Number ...
Cached Biology Technology:Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 2Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 3Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 4Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 5Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 6Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 7Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 8Optimizing Your Benchscale Fermentation Process 2Optimizing Your Benchscale Fermentation Process 3E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor 2E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor 3E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor 4E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor 5E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor 6
(Date:8/27/2014)... of seven hours ago the Happy Camp Complex of ... California, the July complex had consumed 35,530 as of ... fires on the Happy Camp Ranger District of the ... area on August 11, 2014. All but three of ... is a list of contained fires and their size ...
(Date:8/26/2014)... St. Louis have developed algorithms to identify weak spots ... breaking. The technology, which needs to be refined before ... pinpoint minor strains and tiny injuries in the body,s ... is available online Aug. 27 in the Journal ... at the nexus of the physical and life sciences. ...
(Date:8/26/2014)... recent years, increasing pressure from policymakers, consumers, and ... that go beyond reducing the pollutants they emit ... lakes. Today companies must also assess environmental performance ... mining of primary materials to the use and ... given rise to the discipline known as life ...
Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Yale journal explores advances in sustainable manufacturing 2
... Marine conservationists from Plymouth University, and the Universidad Federal ... years analysing the diversity and density of coral colonies ... with the catastrophic El Nio event of 1997-98, creating ... long-term impact a major environmental incident of this nature ...
... in ecology has centered on the role of microbes ... of print in the journal Applied and Environmental ... Sydney, Australia, and collaborators show how changes in the ... mitigation at ecosystem levels. "Ecological theories developed ...
... grades haunt your students. A new study in the ... biology courses is a strong predictor of performance in high-level ... students over 7 years, researchers from Kansas State University found ... in a rigorous genetics course. This result was not surprising, ...
Cached Biology News:Catastrophic climatic events leave corals facing a decade-long fight for recovery 2
Bovine Serum...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Quartz-Halogen, 100 W, High Intensity...
Biology Products: